EHAB - Enhabit, Inc.

Enhabit Home Health & Hospice Announces New Chief Executive Officer

DALLAS--(BUSINESS WIRE)--Enhabit, Inc., a leading home health and hospice provider, today announced that Dale Clift has been appointed president and CEO, following the successful completion of the company's acquisition by Kinderhook Industries. Clift succeeds Barb Jacobsmeyer, former president and CEO of Enhabit, who previously announced her intention to step down upon the appointment of a successor. Clift brings decades of leadership experience in home health and hospice care. He previously se.

May 18, 2026 12:17 PM • businesswire.com

Fast-paced Momentum Stock Enhabit (EHAB) Is Still Trading at a Bargain

If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Enhabit (EHAB) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.

May 14, 2026 05:55 AM • zacks.com

Enhabit (EHAB) Upgraded to Buy: Here's Why

Enhabit (EHAB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

May 13, 2026 09:01 AM • zacks.com

Enhabit, Inc. (NYSE:EHAB) Receives Consensus Rating of “Hold” from Brokerages

Enhabit, Inc. (NYSE: EHAB - Get Free Report) has been given a consensus recommendation of "Hold" by the nine ratings firms that are covering the firm, MarketBeat.com reports. One analyst has rated the stock with a sell rating, six have assigned a hold rating and two have issued a buy rating on the company. The average

Apr 23, 2026 12:24 AM • defenseworld.net

Are CCO, EHAB, APLS, VRE Obtaining Fair Deals for their Shareholders?

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws

Apr 20, 2026 02:59 PM • prnewswire.com

Enhabit Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Enhabit, Inc. - EHAB

NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Enhabit, Inc. (NYSE: EHAB) to Kinderhook Industries, LLC. Under the terms of the proposed transaction, shareholders of Enhabit will receive $13.80 per share in cash. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration.

Apr 20, 2026 12:00 PM • businesswire.com (Hide legal announcements)

Enhabit Sets Stockholder Meeting Date of May 12, 2026, to Approve Transaction with Kinderhook

DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB) (“Enhabit” or the “Company”), a leading home health and hospice care provider, today announced that it will hold the special meeting of stockholders (the “Special Meeting”) on May 12, 2026, at 8 a.m. CDT, to vote on the previously announced agreement and plan of merger (the “Merger Agreement”). Pursuant to the Merger Agreement, Anchor Merger Sub, Inc., a Delaware corporation (“Merger Sub”) and a wholly owned subsidiary of Anchor Parent, LLC (“.

Apr 16, 2026 12:15 PM • businesswire.com

JPMorgan Chase & Co. Sells 271,731 Shares of Enhabit, Inc. $EHAB

JPMorgan Chase and Co. lowered its holdings in shares of Enhabit, Inc. (NYSE: EHAB) by 48.2% during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 291,823 shares of the company's stock after selling 271,731 shares during the period. JPMorgan

Apr 07, 2026 01:03 AM • defenseworld.net

Comparing Enhabit (NYSE:EHAB) & Selectis Health (OTCMKTS:GBCS)

Selectis Health (OTCMKTS:GBCS - Get Free Report) and Enhabit (NYSE: EHAB - Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, profitability, dividends, valuation, earnings, risk and analyst recommendations. Analyst Recommendations This is a breakdown of current

Mar 24, 2026 10:46 PM • defenseworld.net

8 Knots Management LLC Has $33.79 Million Position in Enhabit, Inc. $EHAB

8 Knots Management LLC boosted its stake in shares of Enhabit, Inc. (NYSE: EHAB) by 9.5% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 4,218,846 shares of the company's stock after purchasing an additional 365,779 shares during the quarter. Enhabit comprises 3.8%

Mar 14, 2026 11:23 PM • defenseworld.net

Dynamic Technology Lab Private Ltd Has $253,000 Stake in Enhabit, Inc. $EHAB

Dynamic Technology Lab Private Ltd reduced its holdings in shares of Enhabit, Inc. (NYSE: EHAB) by 57.6% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 31,541 shares of the company's stock after selling 42,823 shares during the period.

Mar 13, 2026 12:06 AM • defenseworld.net

Hidden Gems for Nervous Investors: 4 Safe Haven Stocks Flying Below the Radar

With the CBOE Volatility Index (VIX) sitting at 25.50 and up 34.9% over the past month, investors are increasingly rotating toward names that offer stability, predictable income, and low correlation to broader market swings.

Mar 10, 2026 04:40 AM • 247wallst.com

Agilon Health (NYSE:AGL) versus Enhabit (NYSE:EHAB) Head to Head Comparison

Enhabit (NYSE: EHAB - Get Free Report) and Agilon Health (NYSE: AGL - Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, profitability, dividends, valuation, analyst recommendations, risk and earnings. Analyst Ratings This is a breakdown of current

Mar 07, 2026 08:10 PM • defenseworld.net

The M&A Class Action Firm Encourages $hareholders to Contact Monteverde Concerning the Merger—ACLX, VRE, EHAB, and CECO

NEW YORK, March 05, 2026 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde and Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2025 ISS Securities Class Action Services Report.

Mar 05, 2026 07:35 AM • globenewswire.com (Hide legal announcements)

Shareholder Investigation Launched by Kaskela Law Firm into Fairness of Enhabit, Inc. (NYSE: EHAB) Buyout Price; EHAB Investors Encouraged to Contact the Firm

PHILADELPHIA, March 05, 2026 (GLOBE NEWSWIRE) -- Kaskela Law LLC has launched an investigation into the fairness of the recently announced proposed buyout of Enhabit, Inc. (NYSE: EHAB) shareholders to determine whether the $13.80 per share buyout price undervalues the company's shares.  Click here to request additional information:  https://kaskelalaw.com/case/enhabit/ On February 23, 2026, Enhabit announced that it had agreed to be acquired by private equity firm Kinderhook Industries at a price of $13.80 per share in cash.

Mar 05, 2026 01:00 AM • globenewswire.com (Hide legal announcements)

Enhabit (EHAB) Matches Q4 Earnings Estimates

Enhabit (EHAB) came out with quarterly earnings of $0.14 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.04 per share a year ago.

Mar 04, 2026 01:55 PM • zacks.com

Enhabit Reports Fourth Quarter 2025 Financial Results

DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice care provider, today reported its results of operations for the fourth quarter ended Dec. 31, 2025. “Our fourth quarter 2025 results capped a pivotal year for Enhabit, delivering an emerging growth story with year over year increases in patient census, revenue and Adjusted EBITDA,” said Barb Jacobsmeyer, CEO and president of Enhabit. “The consistent execution of our strategy throughout the year materially imp.

Mar 04, 2026 11:10 AM • businesswire.com

Enhabit, Inc. (NYSE:EHAB) Receives Consensus Rating of “Hold” from Brokerages

Enhabit, Inc. (NYSE: EHAB - Get Free Report) has earned a consensus rating of "Hold" from the nine research firms that are currently covering the stock, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating, five have given a hold rating and three have given a buy rating to the company.

Mar 03, 2026 11:14 PM • defenseworld.net

Why Fast-paced Mover Enhabit (EHAB) Is a Great Choice for Value Investors

Enhabit (EHAB) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.

Mar 03, 2026 04:55 AM • zacks.com

Enhabit (EHAB) Expected to Announce Earnings on Wednesday

Enhabit (NYSE: EHAB - Get Free Report) is anticipated to release its Q4 2025 results after the market closes on Wednesday, March 4th. Analysts expect Enhabit to post earnings of $0.14 per share and revenue of $270.5590 million for the quarter. Parties may visit the the company's upcoming Q4 2025 earning results page for the latest

Feb 24, 2026 11:58 PM • defenseworld.net

Enhabit downgraded to Neutral from Buy at UBS

$13.80 (was $13.60)

UBS

Feb 23, 2026 08:12 PM • TheFly

Enhabit downgraded to Hold from Buy at Jefferies

$13.80 (was $13.60)

Jefferies

Feb 23, 2026 01:26 PM • TheFly

Enhabit price target raised to $13.80 from $9.50 at Leerink

$13.80 (was $13.60)

Leerink Partners

Feb 23, 2026 10:25 AM • TheFly

Enhabit price target raised to $13.80 from $10.50 at Truist

$13.80 (was $13.60)

Truist Financial

Feb 23, 2026 10:22 AM • TheFly

Enhabit upgraded to Outperform from Perform at Oppenheimer

$14.00 (was $10.74)

Michael Wiederhorn · Oppenheimer

Jan 22, 2026 06:47 AM • TheFly

UBS Upgrades Enhabit Home Health & Hospice (EHAB) to Buy

$12.00 (was $9.51)

Wolfe Research

Jan 08, 2026 03:03 AM • StreetInsider

Enhabit initiated with a Hold at Truist

$10.50 (was $9.44)

Truist Financial

Jan 07, 2026 07:05 AM • TheFly

Enhabit price target raised to $12 from $11 at Jefferies

$12.00 (was $9.72)

Jefferies

Dec 16, 2025 08:39 AM • TheFly

Jefferies Upgrades Enhabit Home Health & Hospice (EHAB) to Buy

$9.50 (was $7.73)

Brian Tanquilut · Jefferies

Dec 09, 2024 04:41 AM • StreetInsider

Enhabit upgraded to Market Perform from Underperform at Leerink

$8.50 (was $8.64)

Whit Mayo · Leerink Partners

May 14, 2024 02:14 AM • TheFly

UBS Initiates Coverage On Enhabit with Sell Rating, Announces Price Target of $12

$12.00 (was $13.99)

UBS

Dec 08, 2022 03:27 AM • Benzinga